Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. - Wikidata - awgldk - TriplyDB

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

http://www.wikidata.org/entity/Q37769529

about

Advanced drug delivery and targeting technologies for the ocular diseases Lipid Nanoparticles for Ocular Gene Delivery Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes Selective gene transfer to the retina using intravitreal ultrasound irradiation Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.Nanoparticles and nanofibers for topical drug delivery.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds.Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.Application of lipid nanoparticles to ocular drug delivery.Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Development of microemulsions for ocular delivery.Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.Relevance of Lipid-Based Products in the Management of Dry Eye Disease.Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application

P2860

Q26747220-5BF8B6BF-4C98-4AD4-91EC-F75C38881737 Q26823895-16D3AF99-472F-4E47-8530-4BB1419A939E Q28479248-DB9BAE25-C07F-4066-A120-F19CEA796B43 Q30511472-E58EAFC1-C9A2-4A30-B6A5-84586A6A36B4 Q34733880-6F95945D-AD27-4410-979E-DE15D149D693 Q36697414-FB5AB277-9A67-46C9-884F-D08E8A0641A6 Q36978587-8530EF02-AC03-46A7-A61B-E2B5F760CEAF Q38558905-3F01EC07-7D7C-4080-880B-CF10A12A5F67 Q38648168-B2A2E640-33A8-4AF5-99BB-F893AA3FF1BF Q38674125-063D6505-C537-4CC8-95E5-B98846D5CADE Q38714705-3A73F1C4-49E7-4E6B-AE3D-862368888533 Q38862505-B144FBAB-FDF5-46F5-AA99-87B798DC015E Q38879552-B1A17035-B422-4FF5-8910-D9E737A71439 Q39103248-76CF7763-B6F4-4BB7-BCD1-AFB3A2021238 Q39210541-55E86064-96B3-4044-B65F-4770A20B2DFE Q40549525-075EA566-0A39-4663-9975-0EA0E4D3EF57 Q43119649-5B3107EB-F5E5-44DF-BDCE-47190EA62FAD Q58716234-57BCE7C6-4080-414D-9BE6-C004014BDBBB

P2860

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

http://www.wikidata.org/entity/Q37769529

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@en

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@nl

type

label

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@en

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@nl

prefLabel

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@en

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@nl

P1433

Q37769529-C8AA1E2E-2398-421F-9904-91353DE79FC9

P1476

Q37769529-95320566-BA92-468A-965E-ED20FFFE8E5A

P2093

Q37769529-43D30184-1C6D-41BB-833E-CB37E974A583

Q37769529-50258AB1-AE04-4997-A3B5-1A6E3E387A3E

Q37769529-502D3BD1-084E-4F67-A124-6FEE2D7CCA47

Q37769529-64E4ED59-DE71-4B23-B43F-C1D62C086324

Q37769529-72D11C11-7930-4053-A0D7-D12EDE08F293

P2860

Q37769529-04E95698-1776-4021-A47C-F7A2E07707A6

Q37769529-102D1DD7-2A91-4FF1-8C3F-E1A04A4D5E5C

Q37769529-158D268C-7B81-4FF7-91C3-BE8F7E6CDDAD

Q37769529-1630E47E-6409-46E1-84DE-2F763521CCED

Q37769529-2263214B-D6F4-4AFE-9BD6-D88F48575CFF

Q37769529-24052465-C30E-41E9-94F7-8F17E8590E33

Q37769529-249560B2-185D-4429-8618-103CE13C5A1A

Q37769529-26FA9416-1BF1-4DEA-B8BB-9B91BBC24311

Q37769529-27CC5172-122F-4933-80F5-D3FB0312E55C

Q37769529-281CE2E7-4D32-4A45-8D42-E9499F9B6ADB

P304

Q37769529-42F74BAE-C7D7-4844-9C5B-069ECA31F04E

P31

Q37769529-65A96434-7BAA-4F30-866B-C31579D62674

P356

Q37769529-7D59CA7B-26CC-48CF-9A0B-B43C91F70261

P433

Q37769529-F8AC00DB-FFCE-4BF7-9DAD-1486EF66BD2B

P478

Q37769529-86D08FE6-EEC6-4CC4-8247-B32041560365

P577

Q37769529-EE51B705-C959-40F8-AF3B-EFF960D9360E

P698

Q37769529-5E7ACC70-78BF-40BA-BAEE-EBBBB6FE0C5D

P921

Q37769529-2696537D-E47E-4570-B476-37A3997E0F32

Q37769529-26C9E2BA-98D7-4A25-ABCC-D4479060A97D

P356

02713681003760168

P1433

Current Eye Research

P1476

Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.

@en

P2093

Eliana B Souto

http://www.w3.org/2001/XMLSchema#string

Elisabet Gonzalez-Mira

http://www.w3.org/2001/XMLSchema#string

Maria Antonia Egea

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Garcia

http://www.w3.org/2001/XMLSchema#string

Slavomira Doktorovova

http://www.w3.org/2001/XMLSchema#string

P2860

Non-steroidal anti inflammatory agents decrease bacterial colonisation of contact lenses and prevent adhesion to human corneal epithelial cells

Effect of 1-butanol on the microstructure of lecithin/water/tripalmitin system.

Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.

Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.

Cataract surgery after intravitreal injection of triamcinolone acetonide.

Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration.

Applications of liposomes in ophthalmology.

Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.

Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

P304

537-552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/02713681003760168

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20597640

http://www.w3.org/2001/XMLSchema#string

P921